Imperial College London

DrGarethGerrard

Faculty of MedicineFaculty of Medicine Centre

Honorary Lecturer
 
 
 
//

Contact

 

+44 (0)20 3313 2177g.gerrard Website

 
 
//

Location

 

G326Hammersmith HospitalHammersmith Campus

//

Summary

 

Guest Lectures

Extending the Scope: Driving Change in Solid Tumour Diagnostics, Ion Torrent Annual Oncology User Meeting, Wellcome Collection, 2019

Knowing the Known Unknowns: Validation and IQC of Clinical Cancer Panels, ThermoFisher Scientific, Clinical Oncology User Day, Wellcome Collection, London, 2018

Targeted Sequencing in Myeloid Disorders, 13th Malaysian Society of Haematology Annual Meeting, Kuala Lumpur, 2016

Molecular Research in Haematology, 13th Malaysian Society of Haematology Annual Meeting, Kuala Lumpur, 2016

Next Generation Sequencing: Is it Ready for Routine Clinical Practice?, 13th Malaysian Society of Haematology Annual Meeting, Kuala Lumpur, 2016

Basics of Molecular Techniques: The Future in Clinical Practice, 13th Malaysian Society of Haematology Annual Scientific Meeting, Kuala Lumpur, 2016

Molecular Biomarkers in CML, John van Geest Cancer Research Centre, Nottingham Trent University, 2013

Genetic Analysis of DBA, Diamond-Blackfan Anaemia UK Meeting, Charing Cross Hotel, 2013

Custom Ion AmpliSeq Panels for use in Molecular Diagnostics, Ion Torrent User Group meeting (Life Technologies), Birmingham, Radisson-Blu Hotel, 2013

Fast Mode Duplex MGB Assay for BCR-ABL1 Monitoring, UK BCR-ABL Group, Royal College of Pathologists, 2012

BCR-ABL1 Quantitation: Towards Standardisation, UK NEQAS Participants Meeting, Sheffield Hallam University, 2011

Duplex qPCR for BCR-ABL1 MRD, CMGS Genetic Technologist Training Day, Birmingham Women's Hospital, 2010

Research Student Supervision

Ale,S, Novel application of Ion Torrent PGM next generation sequencing to screen for mutations in Gastrointestinal Stromal Tumour (GIST)

Bak,B, An Investigation into the Gene Expression of PTEN, Akt & SALL4 in Chronic Myeloid Leukaemia

Chopra,A, Epigenetic Control of Disease Progression Markers in Chronic Myeloid Leukaemia: PTEN, PTENP1, MGMT and DDX43

Cloke,C, WT1 and PRAME measurements in Philadelphia (Ph’) positive CML

Elven,M, Detecting Copy Number Variation using Multiplex Polymerase Chain Reaction-based assays, Multiplex Ligation-Dependent Probe Analysis and Next-Generation Sequencing in Diamond-Blackfan Anaemia

Hill,S, Exploring the expression of Aurora Kinases and PTEN in the progression of Chronic Myeloid Leukaemia

Manning,G, High Resolution Melt Curve Analysis for the Screening of BCR-ABL1 Tyrosine Kinase Domain Mutations in Chronic Myeloid Leukaemia

Patel,A, Genetic and Epigenetic analysis of Myeloproliferative neoplasms and novel application of next generation sequencing to mutation analysis

Pelka,D, Development and Verification of Diagnostic Assays for the Detection of DNA Repair Insufficiency for use in Lynch Syndrome Pre- Screening and Targeted Therapy Stratification

Soriano,L, Disease Progression Markers in Chronic Myeloid Leukaemia: Aurora Kinase A, Aurora Kinase B, INCENP and MGMT